scispace - formally typeset
E

Elif Damla Arisan

Researcher at Gebze Institute of Technology

Publications -  92
Citations -  1019

Elif Damla Arisan is an academic researcher from Gebze Institute of Technology. The author has contributed to research in topics: Apoptosis & Autophagy. The author has an hindex of 15, co-authored 77 publications receiving 706 citations. Previous affiliations of Elif Damla Arisan include Istanbul Kültür University & Sabancı University.

Papers
More filters
Journal ArticleDOI

The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.

TL;DR: KEGG pathway analysis revealed a number of critical pathways linked to the seven identified miRs that may provide insight into the interplay between the virus and comorbidities, and miRNAs may constitute potential and effective therapeutic approaches in COVID-19 and its pathological consequences.
Journal ArticleDOI

Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells

TL;DR: The hypothesis that blocking the PI3K/Akt pathway may further increasedCurcumin-induced apoptosis and overcome forced Bcl-2 expression level mediated autophagic responses against curcumin treatment in MCF-7 cells is supported.
Journal ArticleDOI

The inhibition of PI3K and NFκB promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells

TL;DR: The results indicated that curcumin induced cell cycle arrest at G2/M phase by downregulation of cyclin B1 and Cdc2 and inhibited colony formation in MCF-7wt cells, but Bcl-2 overexpression prevented the inhibition of cell cycle associated proteins afterCurcumin treatment.
Journal ArticleDOI

Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells

TL;DR: The results suggest that the potentiating effect of HA14-1 is drug and cell type specific and may not only depend on the inhibition of Bcl-2, and alteration of other pro-APoptotic or anti-apoptotic B cl-2 family members may dictate the apoptotic response when HA14 -1 is combined with chemotherapeutic drugs.
Journal ArticleDOI

Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation

TL;DR: It is shown that cisplatin triggers a Bak-dependent pathway to induce apoptosis in Bcl-2-overexpressing MCF-7 cells, which requires preferential activation of Bak and p53-mediated upregulation of Noxa protein levels and lipid peroxidation.